Avosentan

Ro 67-0565,SPP-301,SPP301,SPP 301

Avosentan是内皮素(ETA)受体拮抗剂。

目录号
EY2836
EY2836
EY2836
纯度
99.05%
99.05%
99.05%
规格
1 mg
5 mg
10 mg
原价
460
1020
1390
售价
460
1020
1390
库存
现货
现货
现货
订购
订购
订购
订购
订购
订购
  • 生物活性

    Avosentan(Ro 67-0565; SPP-301) is a potent competitive selective ETA receptor antagonistthat was in development for the treatment of diabetic nephropathy. Avosentaninhibits ETA with an IC50 of 3nmol/l which is∼500-folds over ETB. [1]

  • 体外研究

  • 体内研究

  • 激酶实验

  • 细胞实验

  • 动物实验

    Rat strains[2]


    Male double transgenic rats (dTGR) withhuman angiotensinogen and renin genes (hREN) L10 × (hAOGEN) 1623 were obtained(5–6weeks of age, weighing 161 ± 2.6g with an average mean BP of 159 ± 2.6mmHg). Following acclimatization and a health examination, rats were housed ingroups of three in standard cages with wire mesh tops and standardized softwoodbedding, synchronized to a 12-hourlight–dark cycle, at ambient temperature 23 ±2oC. A standard rat diet and tap water were supplied ad libitum.

    Effectof avosentan on diuresis and blood pressure in hypertensive rats

    The purpose of this experimental protocolwas to examine the effect of avosentan on diuresis in hypertensive rats. Avosetanwas administered by gavage to dTGR as single doses (six rats per treatmentgroup: 0.1, 1.0, 10 and 100mg/kg and vehicle). Rats were placed after drugadministration in metabolic cages for 24 h to assess fluid electrolytehomeostasis. On this occasion, the following urine parameters were determinedfor each collection period: water intake (ml), diuresis (ml), Na+ concentration(mmol/L), natriuresis/24 h. After 24h from each dosing, blood samples(approximately 0.3 ml/sample) were collected in all animal groups under lightisoflurane anesthesia. The blood samples were collected in Li-heparinized tubesfor hematocrit measurement.

    In a parallel study, six rats per treatmentgroup were instrumented for telemetry BP recording. A telemetry transducer wasimplanted under anesthetic conditions (isoflurane anesthesia), its catheterintroduced into the abdominal aorta just below the bifurcation of the renalarteries, and the sensor fixed to the peritoneum. 



  • 不同实验动物依据体表面积的等效剂量转换表(数据来源于FDA指南)

    动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 AKm系数


    例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。


  • 参考文献

    [1] Watson AM LJ, Schumacher C, de Gasparo M, Feng B, Thomas MC, Allen TJ, Cooper ME, Jandeleit-Dahm KA. The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice. Diabetologia. 2010;53(1):192-203.
    [more]

    分子式
    C23H21N5O5S
    分子量
    479.51
    CAS号
    290815-26-8
    储存方式
    - 20 ℃长期冷藏储存。冰袋运输
    溶剂(常温)
    DMSO
    10 mM
    Water
    Ethanol

    体内溶解度

  • Clinical Trial Information ( data from http://clinicaltrials.gov )

    注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。

  • 相关化合物库

  • 使用AMQUAR产品发表文献后请联系我们

相关推荐

X
  • 联系人 :
  • 收件地址 :
  • 电话号码 :
  • 单位名称 :
  • 产品货号 :
  • 产品规格 :
  • 发票抬头以及单位税号 :